Data / Drug companies / Olanzapine
Olanzapine: 49 companies and 222 products in the FDA NDC directory
Olanzapine is listed in the FDA National Drug Code Directory by 49 companies, with 222 products in commercial distribution. 208 of the products (93.7%) are marketed under an abbreviated new drug application (ANDA), the generic route. The most common dosage forms are tablet, film coated; tablet, orally disintegrating; tablet, and the newest product started marketing on November 2, 2026.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Companies listing it
- 49
- Products
- 222
- Generic (ANDA) products
- 208 (93.7%)
- Application numbers
- 31
- Routes
- Oral, Intramuscular, Subcutaneous
- Brand names
- Zyprexa, Zyprexa Zydis, Weltruza, Zyprexa Intramuscular
- openFDA record search
- api.fda.gov
Companies that list olanzapine
Ranked by number of products. Finished drugs in commercial distribution.
| Company | Products | Main dosage forms | Main marketing category | Newest product started |
|---|---|---|---|---|
| Remedyrepack Inc. | 15 | tablet, film coated | Generic drugs (ANDA) | August 19, 2026 |
| Coupler LLC | 14 | tablet, film coated; tablet | Generic drugs (ANDA) | September 8, 2026 |
| H2-Pharma, LLC | 11 | tablet; tablet, orally disintegrating | New drug applications (NDA) | April 1, 2004 |
| Apotex Corp. | 10 | tablet, film coated; tablet, orally disintegrating | Generic drugs (ANDA) | April 23, 2012 |
| Aurobindo Pharma Limited | 10 | tablet; tablet, orally disintegrating | Generic drugs (ANDA) | May 15, 2014 |
| Hec Pharm USA Inc. | 10 | tablet; tablet, orally disintegrating | Generic drugs (ANDA) | March 17, 2026 |
| Macleods Pharmaceuticals Limited | 10 | tablet, film coated; tablet, orally disintegrating | Generic drugs (ANDA) | February 27, 2015 |
| Torrent Pharmaceuticals Limited | 10 | tablet; tablet, orally disintegrating | Generic drugs (ANDA) | February 28, 2026 |
| Bryant Ranch Prepack | 7 | tablet, film coated; tablet | Generic drugs (ANDA) | August 22, 2014 |
| Dr. Reddy's Laboratories Limited | 7 | tablet, orally disintegrating; tablet, film coated | Generic drugs (ANDA) | April 23, 2012 |
| NorthStar RxLLC | 7 | tablet, film coated; injection, powder, for solution | Generic drugs (ANDA) | October 16, 2023 |
| Qilu Pharmaceutical Co., Ltd. | 7 | tablet; injection, powder, for solution | Generic drugs (ANDA) | November 11, 2025 |
| Ascend Laboratories, LLC | 6 | tablet | Generic drugs (ANDA) | January 1, 2012 |
| Cadila Pharmaceuticals Limited | 6 | tablet | Generic drugs (ANDA) | February 13, 2019 |
| Golden State Medical Supply, Inc. | 6 | tablet, film coated | Generic drugs (ANDA) | April 23, 2012 |
| Modavar Pharmaceuticals LLC | 6 | tablet | Generic drugs (ANDA) | February 27, 2023 |
| American Health Packaging | 5 | tablet, film coated | Generic drugs (ANDA) | May 22, 2014 |
| NCS HealthCare of Ky, LLC DBA Vangard Labs | 5 | tablet, film coated | Generic drugs (ANDA) | August 22, 2014 |
| Proficient Rx LP | 5 | tablet, film coated | Generic drugs (ANDA) | August 22, 2014 |
| Bionpharma Inc. | 4 | tablet, orally disintegrating | Generic drugs (ANDA) | July 1, 2026 |
| Golden State Medical Supply, Inc. | 4 | tablet, orally disintegrating | Generic drugs (ANDA) | October 24, 2011 |
| Jubilant Cadista Pharmaceuticals Inc. | 4 | tablet, orally disintegrating | Generic drugs (ANDA) | September 13, 2012 |
| Lannett Company, Inc. | 4 | tablet, orally disintegrating | Generic drugs (ANDA) | May 30, 2023 |
| Major Pharmaceuticals | 4 | tablet, film coated | Generic drugs (ANDA) | April 23, 2012 |
| Strides Pharma Science Limited | 4 | tablet, orally disintegrating | Generic drugs (ANDA) | April 11, 2022 |
| Teva Pharmaceuticals USA, Inc. | 4 | tablet, orally disintegrating | Generic drugs (ANDA) | February 17, 2012 |
| Bryant Ranch Prepack | 3 | tablet, orally disintegrating | Generic drugs (ANDA) | October 24, 2011 |
| Cardinal Health 107, LLC | 3 | tablet, film coated | Generic drugs (ANDA) | July 28, 2026 |
| Dr. Reddy's Laboratories Inc. | 3 | tablet, film coated | Generic drugs (ANDA) | December 10, 2013 |
| Preferred Pharmaceuticals Inc. | 3 | tablet, film coated | Generic drugs (ANDA) | September 5, 2025 |
| Teva Pharmaceuticals USA, Inc. | 3 | kit | New drug applications (NDA) | November 2, 2026 |
| Direct_Rx | 2 | tablet, film coated | Generic drugs (ANDA) | September 17, 2024 |
| PD-Rx Pharmaceuticals, Inc. | 2 | tablet, film coated | Generic drugs (ANDA) | August 22, 2014 |
| Sandoz Inc | 2 | injection, powder, for solution | Generic drugs (ANDA) | October 24, 2011 |
| Unit Dose Solutions, Inc. | 2 | tablet, film coated | Generic drugs (ANDA) | June 29, 2026 |
| American Regent, Inc. | 1 | injection, powder, lyophilized, for solution | Generic drugs (ANDA) | June 27, 2012 |
| Anthea Pharma Private Limited | 1 | injection, powder, lyophilized, for solution | Generic drugs (ANDA) | March 5, 2026 |
| Aphena Pharma Solutions - Tennessee, LLC | 1 | tablet, film coated | Generic drugs (ANDA) | April 23, 2012 |
| Bryant Ranch Prepack | 1 | tablet, film coated | Generic drugs (ANDA) | August 22, 2014 |
| Camber Pharmaceuticals, Inc. | 1 | injection, powder, for solution | Generic drugs (ANDA) | March 22, 2023 |
| Eugia US LLC | 1 | injection, powder, lyophilized, for solution | Generic drugs (ANDA) | October 22, 2020 |
| Glenmark Pharmaceuticals Inc., USA | 1 | injection, powder, lyophilized, for solution | Generic drugs (ANDA) | March 5, 2026 |
| Hikma Pharmaceuticals USA Inc. | 1 | injection, powder, for solution | Generic drugs (ANDA) | September 18, 2025 |
| Pai Holdings, LLC DBA Pai Pharma | 1 | injection, powder, for solution | Generic drugs (ANDA) | July 25, 2025 |
| Proficient Rx LP | 1 | tablet, film coated | Generic drugs (ANDA) | August 22, 2014 |
| Proficient Rx LP | 1 | tablet, film coated | Generic drugs (ANDA) | April 23, 2012 |
| Redpharm Drug | 1 | tablet, film coated | Generic drugs (ANDA) | August 22, 2014 |
| Ubi Pharma Inc. | 1 | injection, powder, for solution | Generic drugs (ANDA) | May 8, 2020 |
| XGen Pharmaceuticals DJB, Inc. | 1 | injection, powder, for solution | Generic drugs (ANDA) | August 28, 2025 |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Tablet, film coated | 95 | 42.8% |
| Tablet, orally disintegrating | 57 | 25.7% |
| Tablet | 53 | 23.9% |
| Injection, powder, for solution | 10 | 4.5% |
| Injection, powder, lyophilized, for solution | 4 | 1.8% |
| Kit | 3 | 1.4% |
Marketing categories
| Marketing category | Products | Share |
|---|---|---|
| Generic drugs (ANDA) | 208 | 93.7% |
| New drug applications (NDA) | 14 | 6.3% |
Pharmacologic classes
| Class | Products |
|---|---|
| Atypical Antipsychotic | 219 |
Updated November 6, 2026. Read from US Food and Drug Administration, National Drug Code Directory (openFDA). CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.